Hala Mohamed Abu Shady

Hala Mohamed Abu Shady

Auto-generated profile, based on publicly available information

Hala Mohamed Abu Shady

Department of Microbiology, Faculty of Science, Ain Shams University, Cairo, Egypt

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2012 in Egyptian Journal of Medical Human Genetics
Verified
Journal Article
Open access
RNRasha A. Nasr
Rasha A. Nasr
HAHala M. AbuShady
Hala M. AbuShady
HHHussein S. Hussein
Hussein S. Hussein
In view of the significant negative impact of biofilm mediated infection on patient health and the necessity of a reliable phenotypic method for detecting biofilm producers, this study aimed to determine biofilm producing ability and presence of icaAD gene in clinical staphylococcal isolates as well as to assess the reliability of two phenotypic methods used for detection of biofilm. A total of 50 staphylococcal strains were isolated from 124 clinical specimen (94 intravascular catheters and 30 blood samples) collected from in-patients at Pediatric Hospital of Ain Shams University. Two phenotypic methods were used for detection of biofilm production; qualitative Congo red agar (CRA) and quantitative Microtiter plate (MTP). PCR was used to determine the presence of icaAD gene. Biofilm production was detected in 23(46%) isolates by CRA and MTP, however, both methods correlated only in 10(20%) of isolates. The icaAD gene was detected in 16(32%) staphylococcal isolates. Correlating phenotypic methods with icaAD gene detection, only 8(50%) of the icaAD positive staphylococci were positive by MTP, while 5(31%) were positive by CRA method. Unexpectedly, 15(30%) and 18 (36%) of the isolates were icaAD negative while MTP and CRA positive, respectively.In conclusion, despite the presence of icaAD gene, it does not always correlate with in vitro biofilm formation. The biofilm-forming ability of some isolates in absence of icaAD gene highlights the importance of further genetic investigations of ica independent biofilm formation mechanisms. Comparing phenotypic methods, MTP remains a better tool for biofilm screening

30 December 2022 in Microbial Cell Factories
Verified
Journal Article
Open access
PDF file
HAHany M. Abdelmoneim
Hany M. Abdelmoneim
TTTarek Taha
Tarek Taha
MEMohamed Elnouby
Mohamed Elnouby
HAHala Mohamed AbuShady
Hala Mohamed AbuShady
Background: The biosynthesis of silver nanoparticles (AgNPs) is an area of interest for researchers due to its eco-friendly approach. The use of biological approaches provides a clean and promising alternative process for the synthesis of AgNPs. We used for the first time the supernatant of Leclercia adecarboxylata THHM under optimal conditions to produce AgNPs with an acceptable antimicrobial activity against important clinical pathogens. Results: In this study, soil bacteria from different locations were isolated and screened for their potential to form AgNPs. The selected isolate, which was found to have the ability to biosynthesize AgNPs, was identified by molecular methods as Leclercia adecarboxylata THHM and its 16S rRNA gene was deposited in GenBank under the accession number OK605882. Different conditions were screened for the maximum production of AgNPs by the selected bacteria. Five independent variables were investigated through optimizations using one variable at a time (OVAT) and the Plackett–Burman experimental design (PBD). The overall optimal parameters for enhancing the biosynthesis of AgNPs using the supernatant of Leclercia adecarboxylata THHM as a novel organism were at an incubation time of 72.0 h, a concentration of 1.5 mM silver nitrate, a temperature of 40.0 °C, a pH of 7.0, and a supernatant concentration of 30% (v/v) under illumination conditions. The biosynthesized AgNPs have been characterized by UV–visible spectroscopy (UV–Vis), transmission electron microscopy (TEM), and Fourier transform infrared spectroscopy (FTIR). The biosynthesized AgNPs showed an absorption peak at 423 nm, spherical shape, and an average particle size of 17.43 nm. FTIR shows the bands at 3321.50, 2160.15, and 1636.33 cm−1 corresponding to the binding vibrations of amine, alkyne nitrile, and primary amine bands, respectively. The biosynthesized AgNPs showed antimicrobial activity against a variety of microbial pathogens of medical importance. Using resazurin-based microtiter dilution, the minimum inhibitory concentration (MIC) values for AgNPs were 500 µg/mL for all microbial pathogens except for Klebsiella pneumoniae ATCC13883, which has a higher MIC value of 1000 µg/mL. Conclusions: The obtained data revealed the successful green production of AgNPs using the supernatant of Leclercia adecarboxylata THHM that can be effectively used as an antimicrobial agent against most human pathogenic microbes.

1 July 2017
Verified
Journal Article
Open access
PDF file
SAsalma Abdelnasser
salma Abdelnasser
SYShaymaa M M Yahya
Shaymaa M M Yahya
WMWafaa F Mohamed
Wafaa F Mohamed
MAMohsen Asker
Mohsen Asker
HSHala M Abu Shady
Hala M Abu Shady
MGMagdy A Gadallah
Magdy A Gadallah
Objective: Exopolysaccharides gained attention as new source for cancer treatment as recent treatments cause side effects and multidrug resistance. Polysaccharides containing sulfur and uronic acids exhibited antioxidant activity, by restoring cell redox regulation, thus inhibiting cell proliferation and cancer formation. Following this context, our study was performed to assess the cytotoxic activity of exopolysaccharides produced by novel Egyptian marine bacterial strains on HepG2 cells. Methods: Bacteria were isolated, purified and cultured through routine microbiological techniques. 16S rRNA gene amplification and sequence analyses, Fourier Transform Infra-red (FTIR), Identification of monosugars by HPLC molecular weight estimation, sulfur content determination and neutral red uptake assay were utilized. Results: BLAST showed that the isolates were related to the Bacillus sp. FTIR analysis indicated that the four EPSs under study contained sulfur as substituent functional group but with different percentage in each EPS. The highest sulfur percentage (46%) appeared in the EPS-6 that was produced by Bacillus flexus isolated from the Mediterranean Sea. HPLC showed that EPSs contained uronic acids which appeared as glucuronic and galacturonic acid in the low molecular weight EPS-6 (4.296×104 g mol-1). Arabinose appeared besides the glucuronic and galacturonic acid residues. EPS-6 showed the highest cytotoxicity, IC50 (218 μg ml-1) which could be correlated to the presence of sulfure and uronic acids in its structure. Conclusion: The novel Firmicutes from the Egyptian saline habitat produced EPSs of cytotoxic activity on hepatocellular carcinoma.

15 December 2025 in Gut Pathogens
Verified
Journal Article
Open access
PDF file
MAMenna M. M. Mohammed Ali
Menna M. M. Mohammed Ali
HSHala Mohamed Abu Shady
Hala Mohamed Abu Shady
SMSayed. M. M
Sayed. M. M
Hayam A. E. SayedHayam A. E. Sayed
Hayam A. E. Sayed
Background: Helicobacter pylori is a significant global health issue, infecting nearly half of the population. Increasing antibiotic resistance leads to treatment failures. This study examined the antibacterial effects of chamomile ethanolic extract, both alone and combined with standard antibiotics, as a potential approach to fighting antibiotic-resistant H. pylori strains. Methods: Thirty antral gastric biopsies were collected from patients undergoing diagnostic upper endoscopy at El-Demerdash Hospital in Cairo, Egypt. H. pylori isolates were identified by rapid urease test (RUT), cultured, and tested for antimicrobial susceptibility to clarithromycin (CLR, 15 µg), metronidazole (MET, 5 µg), amoxicillin (AX, 25 µg), tetracycline (TE, 30 µg), rifampicin (RA, 30 µg), and levofloxacin (LEV, 5 µg). The minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) were determined. The antibacterial activity of chamomile ethanolic extract was tested alone and in combination with these antibiotics. Phytochemical profiling was conducted using FT-IR and GC-MS. The identified compounds were analyzed through molecular docking against ten H. pylori targets: lipoprotein 20 (LPP20, HP1456), aspartate α-decarboxylase (ADC), S-ribosylhomocysteinase (LuxS), GTP cyclohydrolase II (GCH II), cytotoxin-associated gene A (CagA), sialic acid-binding adhesin (SabA), blood group antigen-binding adhesin (BabA), vacuolating cytotoxin A (VacA), and fructose-1,6-bisphosphate aldolase (FBA), using AutoDock Vina 1.5.7. Results: All thirty biopsies tested positive for RUT, although only 20 yielded successful cultures. The chamomile ethanolic extract demonstrated anti- H. pylori activity against all 20 isolates, with MIC values ranging from 1.562 to 6.25 mg/mL and MBC values from 3.12 to 12.5 mg/mL. When combined with antibiotics, the extract altered their antibacterial activity, primarily producing synergistic effects, while a few combinations exhibited antagonistic effects. Notably, in cases where antibiotics alone had limited activity, adding chamomile extract significantly enhanced effectiveness, increasing inhibition zones by 2.2-fold for tetracycline, 2.1-fold for rifampicin, and 1.7–2.3-fold for levofloxacin. FT-IR analysis confirmed the chemical safety of the extract, while GC-MS profiling identified 38 constituents, including 14 compounds with known antimicrobial properties. Molecular docking revealed strong binding affinities of eight bioactive compounds toward H. pylori target proteins. Additionally, Lipinski’s Rule of Five and ADMET profiling indicated these compounds possess favorable drug-like properties, including safety and oral bioavailability. Conclusions: Chamomile ethanolic extract shows promising anti- H. pylori activity and can enhance the effectiveness of standard antibiotics, indicating its potential as a complementary treatment to combat antibiotic-resistant H. pylori infections.